Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Availability of new psychiatric medications, especially antipsychotics, in context of patient rights and destigmatization of psychiatric patients (CROSBI ID 213861)

Prilog u časopisu | stručni rad

Jukić, Vlado ; Savić, Aleksandar ; Herceg, Miroslav Availability of new psychiatric medications, especially antipsychotics, in context of patient rights and destigmatization of psychiatric patients // Psychiatria Danubina, 23 (2011), 3; 316-319

Podaci o odgovornosti

Jukić, Vlado ; Savić, Aleksandar ; Herceg, Miroslav

engleski

Availability of new psychiatric medications, especially antipsychotics, in context of patient rights and destigmatization of psychiatric patients

Mental disorders carry significant burden that affects patients, their families and the society. Negative perception of psychiatric patients, in particular those with schizophrenia spectrum disorders, and mental disorders in general, even among medical professionals and health care administrators, might stop psychiatric patients from getting the highest standard of care and newest psychopharmacs and treatment options available. Availability of newest medications might provisionally be used as an indicator of stigma of mental health disorders within health care system. Antipsychotics show complex influence on stigma of the disease. While adverse effects and the symbolic meaning of having to take psychiatric medications are clearly seen as stigmatizing, we tend to neglect the fact that by reducing symptoms and improving patient's social functioning antipsychotics enable destigamatization and social inclusion. The recognized unmet need in treating mental disorders and averting the disease burden, and meaningful destigmatization, can be addressed adequately only if psychiatric patients are allowed unrestricted access to newest medications and treatment options.

antipsychotics; patient rights; destigmatization; schizophrenia

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

23 (3)

2011.

316-319

objavljeno

0353-5053

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost